Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip

Biomaterials

Volumn 110, Issue , 2016, Pages 45-59

  Zhang, Yu Shrike ^a,b,c   Arneri, Andrea ^a,b,d   Bersini, Simone ^a,b,e   Shin, Su Ryon ^a,b,c   Zhu, Kai ^a,b,h   Goli Malekabadi, Zahra ^a,b,i   Aleman, Julio ^a,b   Colosi, Cristina ^a,b,j   Busignani, Fabio ^a,b,k   Dell'Erba, Valeria ^a,b,k   Bishop, Colin ^l   Shupe, Thomas ^l   Demarchi, Danilo ^k   Moretti, Matteo ^e,f,g   Rasponi, Marco ^d   Dokmeci, Mehmet Remzi ^a,b,c   Atala, Anthony ^l   Khademhosseini, Ali ^a,b,c,m,n  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c HARVARD UNIVERSITY   (United States)

^d POLITECNICO DI MILANO   (Italy)

^e IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^f Swiss Institute for Regnerative Medicine   (Switzerland)

^g DIVISION OF CARDIOLOGY   (Switzerland)

^h FUDAN UNIVERSITY   (China)

ⁱ AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

^j SAPIENZA UNIVERSITY OF ROME   (Italy)

^k POLITECNICO DI TORINO   (Italy)

^l WAKE FOREST SCHOOL OF MEDICINE   (United States)

^m Konkuk University   (South Korea)

ⁿ KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

more..

Author keywords

Bioprinting; Cardiac tissue engineering; Cardiovascular toxicity; Heart on a chip; Vascularization

Indexed keywords

3D PRINTERS; BLOOD VESSELS; DIAGNOSIS; ENDOTHELIAL CELLS; HEART; HYDROGELS; SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE; TISSUE ENGINEERING; TOXICITY;

BIOPRINTING; CARDIAC TISSUE ENGINEERING; HIERARCHICAL STRUCTURES; HYDROGEL SCAFFOLDS; INDUCED PLURIPOTENT STEM CELLS; PERFUSION BIOREACTOR; REGENERATIVE MEDICINE; VASCULARIZATION;

THREE DIMENSIONAL COMPUTER GRAPHICS;

ALPHA ACTININ; CARDIOVASCULAR AGENT; CONNEXIN 43; DOXORUBICIN; VASCULOTROPIN;

ANISOTROPY; ARTICLE; BIOPRINTING; BIOREACTOR; BIOREACTOR DESIGN; BLOOD VESSEL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CARDIOTOXICITY; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOPLASM; DRUG SCREENING; ENDOTHELIALIZED HEART ON A CHIP; ENDOTHELIALIZED MYOCARDIUM ON A CHIP; ENDOTHELIUM CELL; HEART CONTRACTION; HUMAN; HUMAN CELL; HYDROGEL; INDUCED PLURIPOTENT STEM CELL; MICROFLUIDICS; MOLECULAR HYBRIDIZATION; NANOFABRICATION; PERSONALIZED MEDICINE; PRIORITY JOURNAL; THREE DIMENSIONAL PRINTING; TISSUE ENGINEERING; TISSUE SCAFFOLD; VASCULARIZATION; CHEMISTRY; CYTOLOGY; FIBER; GROWTH, DEVELOPMENT AND AGING; METABOLISM; ORGANOID; PRECLINICAL STUDY; PROCEDURES; REGENERATIVE MEDICINE;

BIOPRINTING; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL CELLS; HUMANS; HYDROGELS; MICROFIBRILS; MYOCARDIUM; MYOCYTES, CARDIAC; ORGANOIDS; PRINTING, THREE-DIMENSIONAL; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84989278478     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.09.003     Document Type: Article

References (88)

1. [1] Chiu, L., Iyer, R.K., Reis, L.A., Nunes, S.S., Radisic, M., Cardiac tissue engineering: current state and perspectives. Front. Biosci. 17 (2011), 1533–1550.
2. [2] Chiu, L.L., Radisic, M., Cardiac tissue engineering. Curr. Opin. Chem. Eng. 2 (2013), 41–52.
3. [3] Zhang, Y.S., Aleman, J., Arneri, A., Bersini, S., Piraino, F., Shin, S.R., et al. From cardiac tissue engineering to heart-on-a-chip: beating challenges. Biomed. Mater, 10, 2015, 034006.
4. [4] Bhise, N.S., Ribas, J., Manoharan, V., Zhang, Y.S., Polini, A., Massa, S., et al. Organ-on-a-chip platforms for studying drug delivery systems. J. Control. Release 190 (2014), 82–93.
5. [5] Zhang, Y.S., Khademhosseini, A., Seeking the Right context for evaluating nanomedicine: from tissue models in petri dishes to microfluidic organs-on-a-chip. Nanomedicine 10 (2015), 685–688.
6. [6] Huh, D., Torisawa, Y-s, Hamilton, G.A., Kim, H.J., Ingber, D.E., Microengineered physiological biomimicry: organs-on-Chips. Lab. Chip. 12 (2012), 2156–2164.
7. [7] Agarwal, A., Goss, J.A., Cho, A., McCain, M.L., Parker, K.K., Microfluidic heart on a chip for higher throughput pharmacological studies. Lab. Chip. 13 (2013), 3599–3608.
8. [8] Selimović, Š., Dokmeci, M.R., Khademhosseini, A., Organs-on-a-chip for drug discovery. Curr. Opin. Pharmacol. 13 (2013), 829–833.
9. [9] Esch, E.W., Bahinski, A., Huh, D., Organs-on-chips at the frontiers of drug discovery. Nat. Rev. Drug Discov. 14 (2015), 248–260.
10. [10] Yum, K., Hong, S.G., Healy, K.E., Lee, L.P., Physiologically relevant organs on chips. Biotechnol. J. 9 (2014), 16–27.
11. [11] Mathur, A., Loskill, P., Shao, K., Huebsch, N., Hong, S., Marcus, S.G., et al. Human iPSC-based cardiac microphysiological system for drug screening applications. Sci. Rep., 5, 2015, 8883.
12. [12] Ma, Z., Koo, S., Finnegan, M.A., Loskill, P., Huebsch, N., Marks, N.C., et al. Three-dimensional filamentous human diseased cardiac tissue model. Biomaterials 35 (2014), 1367–1377.
13. [13] Wang, G., McCain, M.L., Yang, L., He, A., Pasqualini, F.S., Agarwal, A., et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat. Med. 20 (2014), 616–623.
14. [14] Laflamme, M.A., Murry, C.E., Heart regeneration. Nature 473 (2011), 326–335.
15. [15] Robinton, D.A., Daley, G.Q., The promise of induced pluripotent stem cells in research and therapy. Nature 481 (2012), 295–305.
16. [16] Yamanaka, S., Induced pluripotent stem cells: past, present, and future. Cell stem cell 10 (2012), 678–684.
17. [17] Camci-Unal, G., Annabi, N., Dokmeci, M.R., Liao, R., Khademhosseini, A., Hydrogels for cardiac tissue engineering. NPG Asia Mater., 6, 2014, e99.
18. [18] Annabi, N., Tsang, K., Mithieux, S.M., Nikkhah, M., Ameri, A., Khademhosseini, A., et al. Highly elastic micropatterned hydrogel for engineering functional cardiac tissue. Adv. Funct. Mater 23 (2013), 4950–4959.
19. [19] Rouwkema, J., Rivron, N.C., van Blitterswijk, C.A., Vascularization in tissue engineering. Trends Biotechnol. 26 (2008), 434–441.
20. [20] Bae, H., Puranik, A.S., Gauvin, R., Edalat, F., Carrillo-Conde, B., Peppas, N.A., et al. Building vascular networks. Sci. Transl. Med., 4, 2012 160ps23-ps23.
21. [21] Bartholomä, P., Gorjup, E., Monz, D., Reininger-Mack, A., Thielecke, H., Robitzki, A., Three-dimensional in vitro reaggregates of embryonic cardiomyocytes: a potential model system for monitoring effects of bioactive agents. J. Biomol. Screen 10 (2005), 814–822.
22. [22] Messina, E., De Angelis, L., Frati, G., Morrone, S., Chimenti, S., Fiordaliso, F., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95 (2004), 911–921.
23. [23] Chia, S.L., Tay, C.Y., Setyawati, M.I., Leong, D.T., Biomimicry 3D gastrointestinal spheroid platform for the assessment of toxicity and inflammatory effects of zinc oxide nanoparticles. Small 11 (2015), 702–712.
24. [24] Kim, B., Han, G., Toley, B.J., C-k, Kim, Rotello, V.M., Forbes, N.S., Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat. Nanotechnol. 5 (2010), 465–472.
25. [25] Zhang, Y.S., Xia, Y., Multiple facets for extracellular matrix mimicking in regenerative medicine. Nanomedicine 10 (2015), 689–692.
26. [26] Engelmayr, G.C., Cheng, M., Bettinger, C.J., Borenstein, J.T., Langer, R., Freed, L.E., Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat. Mater 7 (2008), 1003–1010.
27. [27] Nunes, S.S., Miklas, J.W., Liu, J., Aschar-Sobbi, R., Xiao, Y., Zhang, B., et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 10 (2013), 781–787.
28. [28] Caspi, O., Lesman, A., Basevitch, Y., Gepstein, A., Arbel, G., Habib, I.H.M., et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 100 (2007), 263–272.
29. [29] Sakaguchi, K., Shimizu, T., Okano, T., Construction of three-dimensional vascularized cardiac tissue with cell sheet engineering. J. Control. Release 205 (2015), 83–88.
30. [30] Chia, S.L., Tay, C.Y., Setyawati, M.I., Leong, D.T., Decoupling the direct and indirect biological effects of ZnO nanoparticles using a communicative dual cell-type tissue construct. Small 12 (2016), 647–657.
31. [31] Setyawati, M.I., Mochalin, V.N., Leong, D.T., Tuning endothelial permeability with functionalized nanodiamonds. ACS Nano 10 (2016), 1170–1181.
32. [32] Murphy, S.V., Atala, A., 3D bioprinting of tissues and organs. Nat. Biotechnol. 32 (2014), 773–785.
33. [33] Malda, J., Visser, J., Melchels, F.P., Jüngst, T., Hennink, W.E., Dhert, W.J.A., et al. 25th anniversary article: engineering hydrogels for biofabrication. Adv. Mater 25 (2013), 5011–5028.
34. [34] Bertassoni, L.E., Cecconi, M., Manoharan, V., Nikkhah, M., Hjortnaes, J., Cristino, A.L., et al. Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs. Lab. Chip. 14 (2014), 2202–2211.
35. [35] Kolesky, D.B., Truby, R.L., Gladman, A.S., Busbee, T.A., Homan, K.A., Lewis, J.A., 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv. Mater 26 (2014), 3124–3130.
36. [36] Lee, V.K., Kim, D.Y., Ngo, H., Lee, Y., Seo, L., Yoo, S.-S., et al. Creating perfused functional vascular channels using 3D bio-printing technology. Biomaterials 35 (2014), 8092–8102.
37. [37] Colosi, C., Shin, S.R., Manoharan, V., Massa, S., Constantini, M., Barbetta, A., et al. Microfluidic bioprinting of heterogeneous 3D tissue constructs using low viscosity bioink. Adv. Mater 28 (2015), 677–684.
38. [38] Gao, Q., He, Y., Fu, J-z, Liu, A., Ma, L., Coaxial nozzle-assisted 3D bioprinting with built-in microchannels for nutrients delivery. Biomaterials 61 (2015), 203–215.
39. [39] Khademhosseini, A., Eng, G., Yeh, J., Kucharczyk, P., Langer, R., Vunjak-Novakovic, G., et al. Microfluidic patterning for fabrication of contractile cardiac organoids. Biomed. Microdevices 9 (2007), 149–157.
40. [40] Bhise, N.S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., et al. A liver-on-a-chip platform with bioprinted hepatic spheroids. Biofabrication, 8, 2016, 014101.
41. [41] Merkel, T.C., Bondar, V.I., Nagai, K., Freeman, B.D., Pinnau, I., Gas sorption, diffusion, and permeation in poly (dimethylsiloxane). J. Polym. Sci. Part B Polym. Phys. 38 (2000), 415–434.
42. [42] Abaci, H.E., Truitt, R., Tan, S., Gerecht, S., Unforeseen decreases in dissolved oxygen levels affect tube formation kinetics in collagen gels. Am. J. Physiol.-Cell Physiol. 301 (2011), C431–C440.
43. [43] Radisic, M., Deen, W., Langer, R., Vunjak-Novakovic, G., Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am. J. Physiol. - Heart Circ. Physiol. 288 (2005), H1278–H1289.
44. [44] Kaemmerer, E., Melchels, F.P.W., Holzapfel, B.M., Meckel, T., Hutmacher, D.W., Loessner, D., Gelatine methacrylamide-based hydrogels: an alternative three-dimensional cancer cell culture system. Acta Biomater. 10 (2014), 2551–2562.
45. [45] Wikswo, J.P., Curtis, E.L., Eagleton, Z.E., Evans, B.C., Kole, A., Hofmeister, L.H., et al. Scaling and systems biology for integrating multiple organs-on-a-chip. Lab. Chip. 13 (2013), 3496–3511.
46. [46] Zhang, Y.S., Ribas, J., Nadhman, A., Aleman, J., Selimović, Š., Lesher-Perez, S.C., et al. A cost-effective fluorescence mini-microscope for biomedical applications. Lab. Chip. 15 (2015), 3661–3669.
47. [47] Rowley, J.A., Madlambayan, G., Mooney, D.J., Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20 (1999), 45–53.
48. [48] Augst, A.D., Kong, H.J., Mooney, D.J., Alginate hydrogels as biomaterials. Macromol. Biosci. 6 (2006), 623–633.
49. [49] Tandon, N., Cannizzaro, C., Chao, P.-H.G., Maidhof, R., Marsano, A., Au, H.T.H., et al. Electrical stimulation systems for cardiac tissue engineering. Nat. Protoc. 4 (2009), 155–173.
50. [50] Moon, J.J., West, J.L., Vascularization of engineered tissues: approaches to promote angiogenesis in biomaterials. Curr. Top. Med. Chem. 8 (2008), 300–310.
51. [51] Choi, S.-W., Zhang, Y., MacEwan, M.R., Xia, Y., Neovascularization in biodegradable inverse opal scaffolds with uniform and precisely controlled pore sizes. Adv. Healthc. Mater 2:1 (2012), 145–154.
52. [52] Lin, R.-Z., Chen, Y.-C., Moreno-Luna, R., Khademhosseini, A., Melero-Martin, J.M., Transdermal regulation of vascular network bioengineering using a photopolymerizable methacrylated gelatin hydrogel. Biomaterials 34 (2013), 6785–6796.
53. [53] Wu, W., DeConinck, A., Lewis, J.A., Omnidirectional printing of 3D microvascular networks. Adv. Mater 23 (2011), H178–H183.
54. [54] Miller, J.S., Stevens, K.R., Yang, M.T., Baker, B.M., Nguyen, D.-H.T., Cohen, D.M., et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat. Mater 11 (2012), 768–774.
55. [55] Aung, A., Theprungsirikul, J., Lim, H.L., Varghese, S., Chemotaxis-driven assembly of endothelial barrier in a tumor-on-a-chip platform. Lab. Chip. 16:10 (2016), 1886–1898.
56. [56] Hutson, C.B., Nichol, J.W., Aubin, H., Bae, H., Yamanlar, S., Al-Haque, S., et al. Synthesis and characterization of tunable poly (ethylene glycol): gelatin methacrylate composite hydrogels. Tissue Eng. A 17 (2011), 1713–1723.
57. [57] Yue, K., Trujillo-de Santiago, G., Alvarez, M.M., Tamayol, A., Annabi, N., Khademhosseini, A., Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials 73 (2015), 254–271.
58. [58] Carola, R., Harley, J.P., Noback, C.R., Human Anatomy and Physiology. 1992, McGraw-Hill College.
59. [59] Radisic, M., Park, H., Shing, H., Consi, T., Schoen, F.J., Langer, R., et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proct Natl. Acad. Sci. U. S. A. 101 (2004), 18129–18134.
60. [60] Shin, S.R., Jung, S.M., Zalabany, M., Kim, K., Zorlutuna, P., Sb, Kim, et al. Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators. ACS Nano 7 (2013), 2369–2380.
61. [61] Kharaziha, M., Shin, S.R., Nikkhah, M., Topkaya, S.N., Masoumi, N., Annabi, N., et al. Tough and flexible CNT–polymeric hybrid scaffolds for engineering cardiac constructs. Biomaterials 35 (2014), 7346–7354.
62. [62] Radisic, M., Marsano, A., Maidhof, R., Wang, Y., Vunjak-Novakovic, G., Cardiac tissue engineering using perfusion bioreactor systems. Nat. Protoc. 3 (2008), 719–738.
63. [63] Radisic, M., Malda, J., Epping, E., Geng, W., Langer, R., Vunjak-Novakovic, G., Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol. Bioeng. 93 (2006), 332–343.
64. [64] Iyer, R.K., Odedra, D., Chiu, L.L.Y., Vunjak-Novakovic, G., Radisic, M., Vascular endothelial growth factor secretion by nonmyocytes modulates Connexin-43 levels in cardiac organoids. Tissue Eng. A 18 (2012), 1771–1783.
65. [65] Madden, L.R., Mortisen, D.J., Sussman, E.M., Dupras, S.K., Fugate, J.A., Cuy, J.L., et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 15211–15216.
66. [66] Shin, S.R., Farzad, R., Tamayol, A., Manoharan, V., Mostafalu, P., Zhang, Y.S., et al. A bioactive carbon nanotube-based ink for printing 2D and 3D flexible electronics. Adv. Mater 28 (2016), 3280–3289.
67. [67] Shin, S.R., Zihlmann, C., Akbari, M., Assawes, P., Cheung, L., Zhang, K., et al. Reduced graphene oxide-gelma hybrid hydrogels as scaffolds for cardiac tissue engineering. Small 12:27 (2016), 3677–3689.
68. [68] Chen, Y.C., Lin, R.Z., Qi, H., Yang, Y., Bae, H., Melero-Martin, J.M., et al. Functional human vascular network generated in photocrosslinkable gelatin methacrylate hydrogels. Adv. Funct. Mater 22 (2012), 2027–2039.
69. [69] Bertassoni, L.E., Cecconi, M., Manoharan, V., Nikkhah, M., Hjortnaes, J., Cristino, A.L., et al. Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs. Lab. Chip. 14 (2014), 2202–2211.
70. [70] Jia, W., Gungor-Ozkerim, P.S., Zhang, Y.S., Yue, K., Zhu, K., Liu, W., et al. Direct 3D bioprinting of perfusable vascular constructs using a blend bioink. Biomaterials 106 (2016), 58–68.
71. [71] Zhang, W., Zhang, Y.S., Bakht, S.M., Aleman, J., Shin, S.R., Yue, K., et al. Elastomeric free-form blood vessels for interconnecting organs on chip systems. Lab. Chip. 16 (2016), 1579–1586.
72. [72] Paul, S.M., Mytelka, D.S., Dunwiddie, C.T., Persinger, C.C., Munos, B.H., Lindborg, S.R., et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov. 9 (2010), 203–214.
73. [73] Shah, R.R., Can pharmacogenetics help rescue drugs withdrawn from the market?. 2006.
74. [74] Schiller, L.R., Johnson, D.A., Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care. Am. J. Gastroenterol. 103 (2008), 815–819.
75. [75] Kaneko, T., Nomura, F., Hamada, T., Abe, Y., Takamori, H., Sakakura, T., et al. On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip. Sci. Rep., 4, 2014.
76. [76] Marsano, A., Conficconi, C., Lemme, M., Occhetta, P., Gaudiello, E., Votta, E., et al. Beating heart on a chip: a novel microfluidic platform to generate functional 3D cardiac microtissues. Lab. Chip. 16 (2016), 599–610.
77. [77] Ribas, J., Sadeghi, H., Manbachi, A., Leijten, J., Brinegar, K., Zhang, Y.S., et al. Cardiovascular organ-on-a-chip platforms for drug discovery and development. Appl. in vitro Toxicol. 2:2 (2016), 82–96.
78. [78] Kim, S.B., Bae, H., Cha, J.M., Moon, S.J., Dokmeci, M.R., Cropek, D.M., et al. A cell-based biosensor for real-time detection of cardiotoxicity using lensfree imaging. Lab. Chip. 11 (2011), 1801–1807.
79. [79] Inoue, H., Yamanaka, S., The use of induced pluripotent stem cells in drug development. Clin. Pharmacol. Ther. 89 (2011), 655–661.
80. [80] Schenke-Layland, K., Nerem, R.M., In vitro human tissue models — moving towards personalized regenerative medicine. Adv. Drug Del Rev. 63 (2011), 195–196.
81. [81] Morimoto, Y., Mori, S., Takeuchi, S., 3D human cardiac muscle on a chip: quantification of contractile force of human iPS-derived cardiomyocytes. 2015 28th IEEE International Conference on Micro Electro Mechanical Systems (MEMS), 2015, IEEE, 566–568.
82. [82] Sato, H., Idiris, A., Miwa, T., Kumagai, H., Microfabric vessels for embryoid body formation and rapid differentiation of pluripotent stem cells. Sci. Rep., 6, 2016, 31063.
83. [83] Tay, C.Y., Muthu, M.S., Chia, S.L., Nguyen, K.T., Feng, S.S., Leong, D.T., Reality check for nanomaterial-mediated therapy with 3D biomimetic culture systems. Adv. Funct. Mater 26 (2016), 4046–4065.
84. [84] Jang, H.L., Zhang, Y.S., Khademhosseini, A., Boosting clinical translation of nanomedicine. Nanomedicine 11 (2016), 1495–1497.
85. [85] Vandergriff, A.C., Hensley, T.M., Henry, E.T., Shen, D., Anthony, S., Zhang, J., et al. Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction. Biomaterials 35 (2014), 8528–8539.
86. [86] Han, J., Kim, B., Shin, J.-Y., Ryu, S., Noh, M., Woo, J., et al. Iron oxide nanoparticle-mediated development of cellular gap junction crosstalk to improve mesenchymal stem cells’ therapeutic efficacy for myocardial infarction. ACS Nano 9 (2015), 2805–2819.
87. [87] Ferreira, M.P., Ranjan, S., Correia, A.M., Mäkilä, E.M., Kinnunen, S.M., Zhang, H., et al. In vitro and in vivo assessment of heart-homing porous silicon nanoparticles. Biomaterials 94 (2016), 93–104.
88. [88] Setyawati, M.I., Tay, C.Y., Chia, S.L., Goh, S.L., Fang, W., Neo, M.J., et al. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE–cadherin. Nat. Commun., 4, 2013, 1673.